Nicotine

Category
stimulant
Half-Life (t½)
PO: 4.3h · SL: 2h · TD: 4.5h · INH: 4.3h
Formula
C10H14N2
Molecular Weight
162.23 g/mol
PubChem CID
89594

Pharmacological Mechanism

nicotinic ach receptor pharmacology agonist (α4β2, α7); releases acetylcholine, dopamine, norepinephrine.

Half-Life & Elimination Curve (PO: 4.3h · SL: 2h · TD: 4.5h · INH: 4.3h)

100%50%25%12.5%0%0h0×t½4.3h1×t½8.6h2×t½12.9h3×t½17.2h4×t½21.5h5×t½0×t½ (0h): 100% remaining (~2.41 µg/L)1×t½ (4.3h): 50% remaining (~1.2 µg/L)2×t½ (8.6h): 25% remaining (~0.602 µg/L)3×t½ (12.9h): 12.5% remaining (~0.301 µg/L)4×t½ (17.2h): 6.3% remaining (~0.15 µg/L)5×t½ (21.5h): 3.1% remaining (~0.0752 µg/L)
Plasma (PO)t½ Decay (4.3h)Effect Site (ke0)
  • 0×t½0h100% (2.41 µg/L)
  • 1×t½4.3h50% (1.2 µg/L)
  • 2×t½8.6h25% (0.602 µg/L)
  • 3×t½12.9h12.5% (0.301 µg/L)
  • 4×t½17.2h6.3% (0.15 µg/L)
  • 5×t½21.5h3.1% (0.0752 µg/L)
Elimination t½4.3h (PO)
Rate Constant (ke)0.161 h⁻¹
Time to Peak (Tmax)3.81h
Est. Peak (Cmax)2.41 µg/L
Clearance (CL)29 L/h
97% Washout (5×t½)21.5h

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Notes

High addiction liability. Avoid nightly use.

Chemical Structure & Identifiers

References